BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

882 related articles for article (PubMed ID: 9691345)

  • 1. [Hepatitis vaccination of adults].
    Jost R
    Schweiz Med Wochenschr; 1998 Jul; 128(27-28):1104-9. PubMed ID: 9691345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preventive vaccination for viral hepatitis].
    Jilg W
    Z Gastroenterol; 1997 Jul; 35(7):585-90. PubMed ID: 9340933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Viral hepatitis: preventable illnesses].
    Baumgarten R
    Z Arztl Fortbild Qualitatssich; 1998 Dec; 92(10):677-80. PubMed ID: 10028595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations for protection against viral hepatitis. Recommendation of the Immunization Practices Advisory Committee. Centers for Disease Control, Department of Health and Human Services.
    Ann Intern Med; 1985 Sep; 103(3):391-402. PubMed ID: 3161440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis vaccination among drug users.
    Quaglio G; Lugoboni F; Mezzelani P; Des Jarlais DC; Lechi A
    Vaccine; 2006 Apr; 24(15):2702-9. PubMed ID: 16436307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations for protection against viral hepatitis.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Jun; 34(22):313-24, 329-35. PubMed ID: 3923311
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prevention of hepatitis A and hepatitis B by vaccination].
    Buisson Y; Meyran M
    Ann Gastroenterol Hepatol (Paris); 1995 Oct; 31(5):306-8; discussion 308-9. PubMed ID: 8572566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vaccination against hepatitis A and B in HCV-infected patient?].
    Blum E
    Internist (Berl); 1998 Sep; 39(9):980. PubMed ID: 9788121
    [No Abstract]   [Full Text] [Related]  

  • 9. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Supplementary statement on hepatitis prevention.
    Can Commun Dis Rep; 1997 Sep; 23():1-6. PubMed ID: 9327646
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis vaccination and prophylaxis.
    Nguyen CT; Tran TT
    Clin Liver Dis; 2009 May; 13(2):317-29. PubMed ID: 19442921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The A's and B's of vaccine-preventable hepatitis: improving prevention in high-risk adults.
    Oldfield EC; Keeffe EB
    Rev Gastroenterol Disord; 2007; 7(1):1-21. PubMed ID: 17392626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral hepatitis: update on prevention.
    Alter MJ
    Henry Ford Hosp Med J; 1984; 32(2):101-6. PubMed ID: 6439691
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of hepatitis A and B.
    Bell S; Watson K
    Aust Fam Physician; 1997 Aug; 26(8):933-6. PubMed ID: 9267058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatitis A and B vaccines].
    Van Cauter J; Pestiaux A; Lenaerts A; Khrouz H
    Rev Med Brux; 1997 Sep; 18(4):187-91. PubMed ID: 9411640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined prevention of hepatitis A and B].
    Fortschr Med; 1997 May; 115(13):18. PubMed ID: 9324474
    [No Abstract]   [Full Text] [Related]  

  • 16. New combined hepatitis A and B vaccine. New vaccine is an adjunct, not an alternative to preventive behaviours.
    Birthistle K; Benbow A
    BMJ; 1998 Apr; 316(7140):1317-8. PubMed ID: 9599053
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
    Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
    Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis vaccines.
    Katkov WN; Dienstag JL
    Gastroenterol Clin North Am; 1995 Mar; 24(1):147-59. PubMed ID: 7729858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Practical considerations of immunoprophylaxis in viral hepatitis].
    Nemesánszky E; Csepregi A
    Orv Hetil; 1998 Aug; 139(31):1835-42. PubMed ID: 9729677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatitis B and C: in view of the treatment options, priority should be given to reaching the groups at risk].
    de Man RA
    Ned Tijdschr Geneeskd; 2007 Oct; 151(43):2365-6. PubMed ID: 18019211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.